Tissue-specificity of insulin action and resistance*

Archives of Physiology and Biochemistry

Volumn 117, Issue 3, 2011, Pages 96-104

  Benito, Manuel ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

cellular models; insulin receptor substrates; insulin resistance; insulin resistance genes; Insulin signalling; mouse models; tissue specificity

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; PROTEIN TYROSINE PHOSPHATASE 1B;

ANIMAL; ANTIBODY SPECIFICITY; BROWN ADIPOSE TISSUE; CONFERENCE PAPER; CYTOLOGY; DISEASE MODEL; GENETICS; HUMAN; INSULIN RESISTANCE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE, BROWN; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLUCOSE; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; ORGAN SPECIFICITY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

MUS;

EID: 79959223244     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2011.563748     Document Type: Conference Paper

References (67)

1. Araki E, Lip es MA, Patti ME, Brüning JC, Haag III BL, Johnson RS, Kahn CR. (1994). Alternative pathway of insulin signalling in mice made with targeted disruption of the IRS-1 gene. Nature 372:186-90. (Pubitemid 24347839)
2. Arribas M, Valverde AM, Benito M. (2003). Role of IRS-3 in the insulin signalling of IRS-1-defcient brown adipocytes. J Biol Chem 278:45189-99. (Pubitemid 37432652)
3. Arribas M, Valverde AM, Burks D, Klein J, Farese RV, White MF, Benito M. (2003). Essential role of protein kinase C ξ in the impairment of insulin-induced glucose transport in IRS-2-defcient brown adipocytes. FEBS Lett 536:161-6. (Pubitemid 36206425)
4. Biddinger SB, Kahn CR. (2006). From mice to men: Insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-58.
5. Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P, Zierath JR. (2002). Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45:1697-702. (Pubitemid 35478139)
6. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR. (2002). Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25-38. (Pubitemid 34778393)
7. Bonner-Weir S. (2000). Life and death of the pancreatic ß-cells. Trends Endocrinol Metab 11:375-8.
8. Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ. (2003). Diferential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic ß-cells. Diabetes 52:974-83. (Pubitemid 36388732)
9. Bruning JC, Michael MD, Winna JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. (1998). A muscle-specifc insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-69. (Pubitemid 128379082)
10. Cline GW, Johnson K, Regitting W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI. (2002). Efects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51:2903-10.
11. Cousin SP, Hugl SR, Myers Jr, MG, White MF, Reifel-Miller A, Rhodes CJ. (1999). Stimulation of pancreatic ß-cell proliferation by growth hormone is glucose-dependent: signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated. Biochem J 344, 649-58. (Pubitemid 30036999)
12. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfne AB, et al. (2009). Identifcation and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509-17.
13. Desbois-Mouthon C, Danan C, Amselem S, Blivet-Van Eggelpoel MJ, Sert-Langeron C, Goosens M, Besmond C, Capeau J, Caron M. (1996). Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor. Metabolism 45:1493-500. (Pubitemid 26424577)
14. Dor Y, Brown J, Martinez OI, Melton DA. (2004). Adult pancreatic ß-cells are formed by self-duplication rather than stem-cell diferentiation. Nature 429:41-6. (Pubitemid 38620543)
15. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. (1998). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-8.
16. Escribano O, Arribas M, Valverde AM, Benito M. (2007). IRS-3 mediates insulin-induced glucose uptake in diferentiated IRS-2-/-brown adipocytes. Mol Cell Endocrinol 268:1-9. (Pubitemid 46437351)
17. Escribano O, Guillén C, Nevado C, Gómez-Hernández A, Kahn CR, Benito M. (2009). Beta-cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreatic endocrine axis through insulin receptor a isoform. Diabetes 58:820-28.
18. Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR. (2001). Essential role of insulin receptor substrate 1 in diferentiation of brown adipocytes. Mol Cell Biol 21:319-29.
19. Ferre T, Riu E, Bosch F, Valera A. (1996). Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10:1213-18. (Pubitemid 26276964)
20. Goldstein BJ, Ahmad F, Ding W, Li PM, Zhang WR. (1998). Regulation of the insulin signalling pathways by cellular protein-tyrosine phosphatases. Mol Cell Biochem 182:91-9. (Pubitemid 28181652)
21. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. (2000). Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb-2 adaptor molecule. J Biol Chem 11:4283-9. (Pubitemid 30094668)
22. González-Rodriguez A, Clampit J, Escribano O, Benito M, Rondinone C, Valverde AM. (2007). Developmental switch from prolonged insulin action to increased sensitivity in PTP1B-defcient hepatocytes. Endocrinology 148:594-608. (Pubitemid 46150776)
23. Gonzalez-Rodriguez A, Nevado C, Escrivá F, Sesti G, Rondinone C, Benito M, Valverde AM. (2008). PTP1B defciency increases glucose uptake in neonatal hepatocytes: involvement of IRA/GLUT2 complexes. Am J Physiol Gastrointest Liver Physiol 295:338-47.
24. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR, Benito M. (2001). Brown adipose tissue specifc insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108:1205-13. (Pubitemid 32995379)
25. Guillen C, Bartolomé A, Nevado C, Benito M. (2008). Insulin induces apoptosis at long term in pancreatic beta cells. FEBS Letters 582:3855-60.
26. Guillén C, Navarro P, Robledo M, Valverde AM, Benito M. (2006). Diferential mitogenic signalling in insulin receptor-defcient foetal pancreatic ß-Cells. Endocrinology 147:1959-68.
27. Hugl SR, White MF, Rhodes CJ. (1998). Insulin-like growth factor I (IGF-I) stimulated pancreatic ß-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 273:17771-9. (Pubitemid 28355120)
28. Kadowaki T. (2000). Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459-65. (Pubitemid 30666378)
29. Kahn CR. (1995). Diabetes. Causes of insulin resistance. Nature 373:384-5.
30. Kahn CR, Bruning JC, Michael MD, Kulkarni RN. (2000). Knockout mice challenge our concepts of glucose homeostasis and the pathogeneis of diabetes mellitus. J Pediatric Endocrinol Metab 13:1377-84. (Pubitemid 32061570)
31. Kitamura T, Kahn CR, Accili D. (2003). Insulin receptor knockout mice. Annu Rev Physiol 65:313-32. (Pubitemid 38249156)
32. Kitamura T, Nakae J, Kitamura I, Kido Y, Biggs WH, Wright CV, White MF, Arden KC, Accili D. (2002). Te forkhead transcrition factor Foxo1 links insulin signalling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110:1839-47. (Pubitemid 36076491)
33. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, et al. (2000). Increased energy expenditure, decreased adiposity and tissue-specifc insulin sensitivity in protein-tyrosine phosphatase 1B-defcient mice. Mol Cell Biol 20:5479-89. (Pubitemid 30482885)
34. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y Komeda K, Nakano R, Miki H, et al. (2000). Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880-89.
35. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. (1999). Tissue-specifc knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-39. (Pubitemid 29077587)
36. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stofel M, Magnuson MA, Kahn CR. (2002). ß-cell-specifc deletion of the IGF-1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter ß-cell mass. Nat Genetics 31:111-15.
37. Kulkarni RN, Jhala US, Winnay J, Krajewski S, Montmini M, Kahn CR. (2004). PDX-1 haploinsufciency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114:828-36. (Pubitemid 39578742)
38. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montmini MR, White MF. (2000). Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109:1193-201. (Pubitemid 34496597)
39. Lavan BE, Lane WS, Lienhard GE. (1997). Te 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272, 11439-43. (Pubitemid 27184151)
40. Lee YH, White MF. (2004). Insulin receptor substrate proteins and diabetes. Arch Phar Res 27:361-70. (Pubitemid 43073729)
41. LeRoith D, Gavrilova O. (2006). Mouse models created to study the pathophysiology of Type 2 diabetes. Int J Biochem Cell Biol 38:904-12. (Pubitemid 43363420)
42. Michael MD, Kulkarni RN, Postic C, Previs SF, Schulman GI, Magnuson MA, Kahn CR. (2000). Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97.
43. Nakae J, Biggs III WH, Kitamura T, Cavenee WK, Wright CE, Arden KC, Accili D. (2002). Regulation of insulin action and pancreatic ß-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genetics 32:245-53.
44. Nakae J, Kitamura T, Silver DL, Accili D. (2001). Te forkhead transcription factor foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359-67. (Pubitemid 33107764)
45. Nandi A, Kitamura Y, Kahn CR, Accili D. (2003). Mouse models of insulin resistance. Physiol Rev 84:623-47. (Pubitemid 38365494)
46. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krutzfeld J, Yin C, Holzember M, Stofel M, Kulkarni RN. (2007). Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 104:8977-982. (Pubitemid 47175422)
47. Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K, Stofel M, Kahn RC, Polonski KS. (2004). Reduced ß-cell mass and altered glucose sensing impair insulin-secretory function in BIRKO mice. Am J Physiol Endocrinol Metab 286:41-9.
48. Previs SF, Withers DJ, Ren JM, White MF, Shulman GI. (2000). Contrasting efects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275:38990-94. (Pubitemid 32058910)
49. Rhodes CJ. (2000). IGF-I and GH post-receptor signalling mechanisms for pancreatic ß-cell replication. J Mol Endocrinol 24:303-11. (Pubitemid 30415004)
50. Roth RA. 1994. Biochemical mechanisms of insulin resistance. Horm Res 41:51-5. (Pubitemid 24180893)
51. Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM. (1996). Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379-85. (Pubitemid 26332902)
52. Smith FE, Rosen KM, Villa-Komarof J, Weir GC, Bonner-Weir S. (1991). Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci USA 88:6152-6. (Pubitemid 21914904)
53. Somwar R, Sumitani S, Taha C, Sweene G, Klip A. (1998). Temporal activation of p70S6 kinase and akt1 by insulin: PI 3-kinase-dependent and-independent mechanisms. Am J Physiol 4:618-25.
54. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG, Glashee E, Lane WS, Pierce JH, White MF. (1995). Role of IRS-2 in insulin and cytokine signalling. Nature 773:173-7.
55. Swenne I. (1992). Pancreatic ß-cell growth and diabetes mellitus. Diabetologia 35:193-201.
56. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Yaburagi Y, Satoh S, et al. (1994). Insulin resistance and growth retardation in mice made with targeted disruption of the IRS-1 gene. Nature 372:182-6. (Pubitemid 24347838)
57. Tobe K, Tamemoto H, Yamaushi T, Aizawa S, Yazaki Y, Kadowaki T. (1995). Identifcation of a 190-Kda protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1. J Biol Chem 270:5698-701.
58. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard C.B. (1998). Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-20. (Pubitemid 28533186)
59. Tseng YH, Kriaciunas KM, Kokkotou E, Kahn CR. (2004). Diferential roles of insulin receptor substrates in brown adipocyte diferentiation. Mol Cell Biol 24, 1918-29. (Pubitemid 38248933)
60. Valera A, Pujol A, Pelegrin M, Bosch F. (1994). Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:9151-4.
61. Valverde AM, Arribas M, Mur C, Navarro P, Pons S, Cassard-Doulcier AM, Kahn CR, Benito M. (2003). Insulin-induced UCP-1 expression is mediated by IRS-1 through phosphatidylinositol 3-kinase/Akt signalling pathway in foetal brown adipocytes. J Biol Chem 278:10221-31. (Pubitemid 36800283)
62. Valverde AM, Burks D, Fabregat I, Fisher T, Carretero J, White MF, Benito M. (2003). Molecular mechanisms of insulin resistance in IRS-2-defcient hepatocytes. Diabetes 52, 2239-48. (Pubitemid 37059493)
63. Valverde AM, Kahn CR, Benito M. (1999). Insulin signalling in insulin receptor substrate (IRS)-1-defcient brown adipocytes: requirement of IRS-1 for lipid synthesis. Diabetes 48, 2122-31. (Pubitemid 29521840)
64. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. (1999). IRS-2 coordinates IGF-I receptor-mediated ß-cell development and peripheral insulin signalling. Nat Genetics 23:32-40. (Pubitemid 29418784)
65. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y Bernal D, Pons S, Shulman GI, et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904. (Pubitemid 28157668)
66. Xiaocheng C, Kyle D, Copps D, Guo S, Li Y, Kollipara R, DePinho RA, White MF. (2008). Inactivation of hepatic foxo1 by insulin signalling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metabolism 8, 65-76. (Pubitemid 351863393)
67. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, et al. (1996). Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate-1-defcient mice. Mol Cell Biol 16:3074-84.